News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
124 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (103)
2 (1)
4 (140)
5 (169)
6 (148)
7 (144)
8 (68)
9 (22)
10 (23)
11 (209)
12 (180)
13 (124)
14 (146)
15 (82)
17 (2)
18 (146)
19 (143)
20 (110)
21 (123)
22 (70)
24 (1)
25 (2)
26 (8)
27 (78)
28 (44)
29 (45)
30 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
24
25
26
27
28
29
30
Genetown
Sobi Launches Orfadin (nitisinone) Ambassador Program to Support Patients and Caregivers Living With Hereditary Tyrosinemia Type 1 (HT-1)
Sobi is proud to introduce the Orfadin Ambassador program, a peer-to-peer education program within the hereditary tyrosinemia type 1 (HT-1) community.
December 13, 2017
·
7 min read
Business
Spectral to Launch Toraymyxin/EAA in Canada in Q1 2018
Spectral announced that the company has entered into a distribution agreement with CASTER MEDICAL SYSTEM (“CMS”) to launch Toraymyxin (“PMX”) and EAA in Canada commencing in the first quarter of 2018.
December 13, 2017
·
3 min read
Business
New Research Partnership Will Leverage BERG Interrogative Biology Platform and Identify Novel Biomarker and Targets for Diagnosis and Treatment of Alzheimer’s Disease
Under the terms of the collaboration, MGH and BWH will provide access to a longitudinal collection of clinically annotated patient-derived biospecimens from the Harvard biomarker study.
December 13, 2017
·
6 min read
Biotech Beach
Cercacor Introducing Android Version of Ember App
Cercacor, makers of Ember announced it has launched an Android version of its Ember app.
December 13, 2017
·
2 min read
Deals
Kangen Pharma Announces Acquisition of KC Specialty Therapeutics.
Kangen intends to retain operations in Kansas City, Kansas, USA, with expansions in Japan and the US.
December 13, 2017
·
2 min read
Drug Development
AbilityPharma Announces FDA Approval of IND for Phase II Trial of ABTL0812 in Patients With Endometrial Cancer or Squamous Non-Small Cell Lung Cancer
The trial is ongoing in Europe, where a total of 80 patients will be enrolled.
December 13, 2017
·
2 min read
Business
IBN Executive Director Professor Jackie Y. Ying Elected Fellow of the U.S. National Academy of Inventors
Prof Ying is the first researcher based in Singapore to receive this recognition.
December 13, 2017
·
6 min read
Toron, Inc. Provides Corporate Status Update
Toron is proud to announce we have entered into a Letter of Intent to acquire InMed.
December 13, 2017
·
2 min read
Drug Development
Glenmark Pharma Announces Top-Line Results From a Phase III Safety Study Evaluating Ryaltris in Patients with Perennial Allergic Rhinitis
Glenmark plans to submit the company’s first NDA to the FDA for Ryaltris for the treatment of patients with SAR in the first quarter of 2018.
December 13, 2017
·
4 min read
Policy
Sanofi Presents R&D Strategy and Innovative Pipeline
The company will highlight the progress it has made against “Sustaining Innovation”, a key pillar of its 2020 strategic roadmap, and advancing a differentiated portfolio addressing unmet needs.
December 13, 2017
·
15 min read
Previous
5 of 13
Next